Pregled bibliografske jedinice broj: 691635
Haemostatic management in high-risk cardiac surgery : a role of recombinant factor VIIa (NovoSeven RT)
Haemostatic management in high-risk cardiac surgery : a role of recombinant factor VIIa (NovoSeven RT) // European journal of cardio-thoracic surgery, 42 (2012), 3; 606-607 doi:10.1093/ejcts/ezs166 (podatak o recenziji nije dostupan, pismo uredniku, znanstveni)
CROSBI ID: 691635 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Haemostatic management in high-risk cardiac surgery : a role of recombinant factor VIIa (NovoSeven RT)
Autori
Petričević, Mate ; Biočina, Bojan ; Konosić, Sanja ; Burcar, Ivan
Izvornik
European journal of cardio-thoracic surgery (1010-7940) 42
(2012), 3;
606-607
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, znanstveni
Ključne riječi
recombinant factor; VIIa factor; VII haemorrhage; re-exploration
Sažetak
We believe that intraoperative haemostatic property optimization guided by viscoelastic tests of whole-blood coagulation and platelet function should precede rFVIIa administration. Such an approach can improve the rFVIIa efficiency and therefore diminish the 11% prevalence of patients requiring re-exploration despite rFVIIa administration. In our experience, algorithms for perioperative coagulation management based on the point-of-care testing permit a fast diagnostic and goal-directed therapy of coagulation and functional platelet disorders with only sporadic need for rFVIIa administration. We congratulate the authors on their elegant and timely research.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
